Pasithea Therapeutics Corp.
KTTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,905 | -$15,508 | -$11,728 | -$2,174 |
| Dep. & Amort. | $649 | $648 | $5 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$2,334 |
| Stock-Based Comp. | $0 | $592 | $0 | $471 |
| Change in WC | -$1,519 | $1,574 | $845 | $111 |
| Other Non-Cash | $851 | -$733 | -$2,814 | $750 |
| Operating Cash Flow | -$13,923 | -$13,425 | -$13,691 | -$3,174 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$34 | -$107 | -$22 |
| Net Acquisitions | $0 | $0 | -$2,193 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $433 | -$627 | $0 |
| Investing Cash Flow | $0 | $399 | -$2,927 | -$22 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,518 | $0 | $0 | $50,237 |
| Stock Repurch. | $0 | -$3,726 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$3,206 | $5,693 |
| Financing Cash Flow | $4,518 | -$3,726 | -$3,206 | $55,929 |
| Forex Effect | -$3 | -$4 | -$55 | -$11 |
| Net Chg. in Cash | -$9,408 | -$16,757 | -$19,879 | $52,723 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,331 | $33,088 | $52,967 | $244 |
| End Cash | $6,923 | $16,331 | $33,088 | $52,967 |
| Free Cash Flow | -$13,923 | -$13,460 | -$13,798 | -$3,196 |